Improvement of muscle strength in specific muscular regions in nusinersen-treated adult patients with 5q-spinal muscular atrophy

Real-world data have shown mild improvement of overall motor function in adult patients treated with nusinersen, the first approved therapy for 5q-spinal muscular atrophy (SMA). However, knowledge about preferably targeted muscle functions is sparse. The aim of this study was to evaluate strength of...

Descripción completa

Detalles Bibliográficos
Autores principales: Schreiber-Katz, Olivia, Siegler, Hannah Alexandra, Wieselmann, Gary, Kumpe, Mareike, Ranxha, Gresa, Petri, Susanne, Osmanovic, Alma
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Nature Publishing Group UK 2023
Materias:
Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10107562/
https://www.ncbi.nlm.nih.gov/pubmed/37069197
http://dx.doi.org/10.1038/s41598-023-31617-5

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10107562/
https://www.ncbi.nlm.nih.gov/pubmed/37069197
http://dx.doi.org/10.1038/s41598-023-31617-5

Ejemplares similares